Zobrazeno 1 - 10
of 582
pro vyhledávání: '"MESH: Anti-Bacterial Agents"'
Autor:
Romain Garreau, Damien Montange, Antoine Grillon, François Jehl, Tristan Ferry, Laurent Bourguignon, Sylvain Goutelle
Publikováno v:
Clinical Pharmacokinetics
Clinical Pharmacokinetics, 2022, 61 (10), pp.1443-1456. ⟨10.1007/s40262-022-01168-5⟩
Clinical Pharmacokinetics, 2022, 61 (10), pp.1443-1456. ⟨10.1007/s40262-022-01168-5⟩
International audience; Background and objective: Daptomycin has been recommended in the treatment of bone and joint infection. Previous work showed that the approved dosage of daptomycin may be insufficient to achieve optimal exposure in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75b6f6222362845aad3fe52a40ec065f
https://doi.org/10.1007/s40262-022-01168-5
https://doi.org/10.1007/s40262-022-01168-5
Autor:
Florent Arregle, Nicolas Iline, Roch Giorgi, Mary Philip, Sandrine Hubert, Frederique Gouriet, Jean Paul Casalta, Frédéric Collart, Alberto Riberi, Hélène Martel, Sébastien Renard, Laurence Camoin, Anne Claire Casalta, Hubert Lepidi, Didier Raoult, Michel Drancourt, Gilbert Habib
Publikováno v:
European Heart Journal: Acute Cardiovascular Care
European Heart Journal: Acute Cardiovascular Care, 2022, 11 (9), pp.672-681. ⟨10.1093/ehjacc/zuac088⟩
European Heart Journal: Acute Cardiovascular Care, 2022, 11 (9), pp.672-681. ⟨10.1093/ehjacc/zuac088⟩
Aims To determine the prognosis of patients treated for infective endocarditis (IE) according to their healthcare pathway. To assess how the ESC guidelines are implemented concerning the performance of transoesophageal echocardiography, the use of an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dee3bb2fab90d8fbd95cdca9ae0085c
https://doi.org/10.1093/ehjacc/zuac088
https://doi.org/10.1093/ehjacc/zuac088
Publikováno v:
Communications Biology
Communications Biology, 2023, 6 (1), pp.275. ⟨10.1038/s42003-023-04601-y⟩
Communications Biology, 2023, 6 (1), pp.275. ⟨10.1038/s42003-023-04601-y⟩
The rise of antibiotic resistance in bacterial pathogens is a major health concern and the determinants of this emergence are actively studied. By contrast, although biofilms are an important cause of infections due to their high tolerance to a broad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff5cfe3f596b67dad18b6fdbb318c1ed
https://hal-pasteur.archives-ouvertes.fr/pasteur-04111698/file/s42003-023-04601-y.pdf
https://hal-pasteur.archives-ouvertes.fr/pasteur-04111698/file/s42003-023-04601-y.pdf
Publikováno v:
Veterinary Research
Veterinary Research, 2022, 53, pp.1-14. ⟨10.1186/s13567-022-01094-1⟩
Veterinary Research, 2022, 53, pp.1-14. ⟨10.1186/s13567-022-01094-1⟩
Bovine respiratory disease (BRD) dramatically affects young calves, especially in fattening facilities, and is difficult to understand, anticipate and control due to the multiplicity of factors involved in the onset and impact of this disease. In thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::565304b03c10756ebf0c53e734a9af35
https://hal.inrae.fr/hal-03796118/file/s13567-022-01094-1.pdf
https://hal.inrae.fr/hal-03796118/file/s13567-022-01094-1.pdf
Autor:
Adrien, Bouglé, Sophie, Tuffet, Laura, Federici, Marc, Leone, Antoine, Monsel, Thomas, Dessalle, Julien, Amour, Claire, Dahyot-Fizelier, François, Barbier, Charles-Edouard, Luyt, Olivier, Langeron, Bernard, Cholley, Julien, Pottecher, Tarik, Hissem, Jean-Yves, Lefrant, Benoit, Veber, Matthieu, Legrand, Alexandre, Demoule, Pierre, Kalfon, Jean-Michel, Constantin, Alexandra, Rousseau, Tabassome, Simon, Arnaud, Foucrier, Nora, Soussi
Publikováno v:
Intensive Care Medicine
Intensive Care Medicine, 2022, 48 (7), pp.841-849. ⟨10.1007/s00134-022-06690-5⟩
Intensive Care Medicine, 2022, 48 (7), pp.841-849. ⟨10.1007/s00134-022-06690-5⟩
International audience; Purpose: Duration of antibiotic therapy for ventilator-associated pneumonia (VAP) due to non-fermenting Gram-negative bacilli (NF-GNB), including Pseudomonas aeruginosa (PA) remains uncertain. We aimed to assess the non-inferi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c7ccc4f208ddc6e58a84d54f3cb86f1
https://doi.org/10.1007/s00134-022-06690-5
https://doi.org/10.1007/s00134-022-06690-5
Autor:
Guillaume Hoffmann, Madalen Le Gorrec, Emeline Mestdach, Stephen Cusack, Loïc Salmon, Malene Ringkjøbing Jensen, Andrés Palencia
Publikováno v:
Journal of the American Chemical Society
Journal of the American Chemical Society, 2023, 145 (2), pp.800-810. ⟨10.1021/jacs.2c04808⟩
Journal of the American Chemical Society, 2023, 145 (2), pp.800-810. ⟨10.1021/jacs.2c04808⟩
Prodrugs have little or no pharmacological activity and are converted to active drugs in the body by enzymes, metabolic reactions, or through human-controlled actions. However, prodrugs promoting their chemical bioconversion without any of these proc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e0d98241992c420eed5e3874901288a
https://hal.science/hal-04025430
https://hal.science/hal-04025430
Autor:
Agnès B. Jousset, Sandrine Bernabeu, Cécile Emeraud, Rémy A. Bonnin, Alexandra Lomont, Jean Ralph Zahar, Audrey Merens, Christophe Isnard, Nathalie Soismier, Eric Farfour, Vincent Fihman, Nicolas Yin, Olivier Barraud, Hervé Jacquier, Anne-Gaëlle Ranc, Frédéric Laurent, Stéphane Corvec, Louise Ruffier d'Epenoux, Emmanuelle Bille, Nicolas Degand, Chloé Plouzeau, Thomas Guillard, Vincent Cattoir, Asaf Mizrahi, Antoine Grillon, Frédéric Janvier, Cécile Le Brun, Marlène Amara, Mathilda Bastide, Alban Lemonnier, Laurent Dortet
Publikováno v:
Journal of Global Antimicrobial Resistance
Journal of Global Antimicrobial Resistance, 2023, 32, pp.78-84. ⟨10.1016/j.jgar.2023.01.003⟩
Journal of Global Antimicrobial Resistance, 2023, 32, pp.78-84. ⟨10.1016/j.jgar.2023.01.003⟩
International audience; Objectives: Ceftolozane-tazobactam (C/T) proved its efficacy for the treatment of infections caused by non-carbapenemase producing Pseudomonas aeruginosa and Enterobacterales. Here, we aimed to provide susceptibility data on l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecd126d3d9f893524ff4e564b1b4de70
https://www.hal.inserm.fr/inserm-03962400/document
https://www.hal.inserm.fr/inserm-03962400/document
Autor:
Manon Janet-Maitre, Stéphane Pont, Frerich M. Masson, Serena Sleiman, Julian Trouillon, Mylène Robert-Genthon, Benoît Gallet, Chantal Dumestre-Perard, Sylvie Elsen, Christine Moriscot, Bart W. Bardoel, Suzan H. M. Rooijakkers, François Cretin, Ina Attrée
Publikováno v:
Plos Pathogens
PLoS Pathogens
PLoS Pathogens, 2023, 1386 (1), pp.325-345. ⟨10.1371/journal.ppat.1011023⟩
PLoS Pathogens, 2023, 19 (1), pp.e1011023. ⟨10.1371/journal.ppat.1011023⟩
PLoS Pathogens
PLoS Pathogens, 2023, 1386 (1), pp.325-345. ⟨10.1371/journal.ppat.1011023⟩
PLoS Pathogens, 2023, 19 (1), pp.e1011023. ⟨10.1371/journal.ppat.1011023⟩
Pseudomonas aeruginosa, an opportunistic Gram-negative pathogen, is a leading cause of bacteremia with a high mortality rate. We recently reported that P. aeruginosa forms a persister-like sub-population of evaders in human plasma. Here, using a gain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc5d10904d3df7086f55b653c76a4602
Autor:
Vincent Jean-Pierre, Agathe Boudet, Pauline Sorlin, Quentin Menetrey, Raphaël Chiron, Jean-Philippe Lavigne, Hélène Marchandin
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2022, 24 (1), pp.597. ⟨10.3390/ijms24010597⟩
International Journal of Molecular Sciences, 2022, 24 (1), pp.597. ⟨10.3390/ijms24010597⟩
International audience; Staphylococcus aureus is a major human pathogen whose characteristics support its success in various clinical settings including Cystic Fibrosis (CF). In CF, S. aureus is indeed the most commonly identified opportunistic patho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::139ba6dc7aeaac86d43d735fa8e942af
https://hal.science/hal-04038884/file/ijms-24-00597.pdf
https://hal.science/hal-04038884/file/ijms-24-00597.pdf
Autor:
Parker L. Flanders, Carlos Contreras-Martel, Nathaniel W. Brown, Joshua D. Shirley, Alexandre Martins, Kelsie N. Nauta, Andréa Dessen, Erin E. Carlson, Elizabeth A. Ambrose
Publikováno v:
ACS Chemical Biology
ACS Chemical Biology, 2022, 17 (11), pp.3110-3120. ⟨10.1021/acschembio.2c00503⟩
ACS Chem Biol
ACS Chemical Biology, 2022, 17 (11), pp.3110-3120. ⟨10.1021/acschembio.2c00503⟩
ACS Chem Biol
International audience; β-Lactam antibiotics comprise one of the most widely used therapeutic classes to combat bacterial infections. This general scaffold has long been known to inhibit bacterial cell wall biosynthesis by inactivating penicillin-bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0783d061071e82755c439d798d76a74
https://hal.science/hal-03969300
https://hal.science/hal-03969300